SCHEMBL1398196

SCHEMBL1398196

Cc1cnc2cccc(OC(=O)O)c2c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.41
HTT P42858 3/20 0.40
ALDH1A1 P00352 3/20 0.40
NPSR1 Q6W5P4 3/20 0.40
HPGD P15428 1/20 0.40
KDM4E B2RXH2 3/20 0.39
MAPT P10636 4/20 0.38
SMN1; SMN2 Q16637 2/20 0.37
KDR P35968 1/20 0.37
POLB P06746 2/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
ESR1 P03372 2/20 0.37
ESR2 Q92731 2/20 0.37
PDE10A Q9Y233 1/20 0.36
FABP5 Q01469 1/20 0.36
HSD17B10 Q99714 1/20 0.36
PARP1 P09874 1/20 0.36
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8967010 0.81 MET (0.44) HTTALDH1A1NPSR1HPGDMAPT
SCHEMBL5221215 0.79 PDE10A (0.48) CYP1A2HTTALDH1A1HPGDKDM4E
SCHEMBL9414452 0.78 EGLN1 (0.40) HTTALDH1A1MAPTMEN1KMT2A
SCHEMBL9411413 0.77 PDE4B (0.43) HTTALDH1A1NPSR1HPGDMAPT
SCHEMBL1398193 0.76 ALDH1A1 (0.47) CYP1A2HTTALDH1A1NPSR1HPGD
SCHEMBL9358679 0.76 PARP1 (0.56) CYP1A2HTTALDH1A1NPSR1KDM4E
SCHEMBL2308927 0.74 FABP5 (0.53) HTTALDH1A1NPSR1KDM4EMAPT
SCHEMBL9411557 0.74 KDM4E (0.44) HTTKDM4ESMN1; SMN2KMT2AESR1
SCHEMBL5545382 0.72 CYP1A2 (0.50) CYP1A2HTTALDH1A1NPSR1HPGD
SCHEMBL5215594 0.72 KDM4E (0.53) CYP1A2HTTALDH1A1NPSR1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2086969-B1 3-CYANO-5-THIAZAHETEROARYL-DIHYDROPYRIDINE AND THE USE THEREOF FOR THE TREATMENT OF CARDIOVASCULAR DISEASES BAYER SCHERING PHARMA AG (DE) 2011-03-02 EP disclosed
EP-2086969-A1 3-CYANO-5-THIAZAHETEROARYL-DIHYDROPYRIDINE AND THE USE THEREOF FOR THE TREATMENT OF CARDIOVASCULAR DISEASES Bayer Schering Pharma AG (DE) 2009-08-12 EP disclosed
WO-2008034534-A1 3-CYANO-5-THIAZAHETEROARYL-DIHYDROPYRIDINE AND THE USE THEREOF FOR THE TREATMENT OF CARDIOVASCULAR DISEASES BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2008-03-27 WO disclosed